Abstract: Real-world dosing of regorafenib in patients with unresectable hepatocellular carcinoma (uHCC): Final analysis of the prospective, observational REFINE study.

Content Format:

PDF

Credit Type:

--

Credits:

--
Slides: Real-world dosing of regorafenib in patients with  unresectable hepatocellular carcinoma (uHCC):  Final analysis of the prospective, observational  REFINE study

Content Format:

Slideset

Credit Type:

--

Credits:

--